Search results
Showing 1 to 15 of 22 results for adrenaline
This quality standard covers care after emergency treatment for suspected anaphylaxis, including assessment and referral to specialist allergy services. It describes high-quality care in priority areas for improvement.
View quality statements for QS119Show all sections
Sections for QS119
- Quality statements
- Quality statement 1: Referral to specialist allergy services after emergency treatment
- Quality statement 2: Education in adrenaline auto-injector use
- Quality statement 3: Specialist assessment for venom immunotherapy
- Quality statement 4 (placeholder): Ongoing training in adrenaline auto-injector use
- Update information
- About this quality standard
Anaphylaxis: assessment and referral after emergency treatment (CG134)
This guideline covers assessment and referral for anaphylaxis. It aims to improve the quality of care for people with suspected anaphylaxis by detailing the assessments that are needed and recommending referral to specialist allergy services.
Acute upper gastrointestinal bleeding in over 16s: management (CG141)
This guideline covers how upper gastrointestinal bleeding can be effectively managed in adults and young people aged 16 years and older. It aims to identify which diagnostic and therapeutic steps are useful so hospitals can develop a structure in which clinical teams can deliver an optimum service for people who develop this condition.
View recommendations for CG141Show all sections
Pharmalgen for the treatment of bee and wasp venom allergy (TA246)
Evidence-based recommendations on bee venom and wasp venom (Pharmalgen) for treating bee and wasp venom allergy.
This guideline covers diagnosing and managing bronchiolitis in babies and children. It aims to help healthcare professionals diagnose bronchiolitis and identify if babies and children should be cared for at home or in hospital. It describes treatments and interventions that can be used to help with the symptoms of bronchiolitis.
This quality standard covers the management of acute upper gastrointestinal bleeding in adults and young people (aged 16 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS38Show all sections
Sections for QS38
- Quality statements
- Quality statement 1: Risk assessment
- Quality statement 2: Immediate endoscopy for people who are haemodynamically unstable
- Quality statement 3: Endoscopy within 24 hours for people who are haemodynamically stable
- Quality statement 4: Endoscopic treatment for non-variceal bleeding
- Quality statement 5: Treatment of non-variceal bleeding after first or failed endoscopic treatment
- Quality statement 6: Prophylactic antibiotic therapy for variceal bleeding
- Quality statement 7: Band ligation for oesophageal variceal bleeding
life of (a) referral to specialist allergy services and (b) provision of adrenaline injectors, when compared with emergency treatment...
life of (a) referral to specialist allergy services and (b) provision of adrenaline injectors, when compared with emergency treatment...
bronchiolitis. One study reported that infants provided with both nebulised adrenaline and systemic steroids had improved clinical...
any emergency treatment that was delivered (by a clinician, use of an adrenaline injector) and the associated outcomes (morbidity,...
What is the annual incidence of anaphylaxis and its related outcomes within the UK?
any emergency treatment that was delivered (by a clinician, use of an adrenaline injector) and the associated outcomes (morbidity,...
Endoscopic submucosal dissection of gastric lesions (IPG360)
Evidence-based recommendations on endoscopic submucosal dissection (ESD) of gastric lesions. This involves inserting a thin telescope through the mouth into the stomach to view the area and removing the lesion with special equipment.
View recommendations for IPG360Show all sections
Sections for IPG360
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia (IPG355)
Evidence-based recommendations on endoscopic submucosal dissection (ESD) of oesophageal dysplasia and neoplasia. This involves inserting a long camera through the mouth into the oesophagus to view the area and removing the abnormal part with special instruments.
View recommendations for IPG355Show all sections
Sections for IPG355
Temperature control to improve neurological outcomes after cardiac arrest (IPG782)
Evidence-based recommendations on temperature control to improve neurological outcomes after cardiac arrest. This involves controlling a person’s body temperature while they are still unconscious after their heart has been restarted. Either their body is kept at a normal temperature of between 36.5°C and 37.5°C to prevent fever, or it is cooled to between 32.0°C and 36.0°C (therapeutic hypothermia).
View recommendations for IPG782Show all sections
Palforzia for treating peanut allergy in children and young people (TA769)
Evidence-based recommendations on Palforzia for treating peanut allergy in children and young people.